EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling

Ruijia Wen iD, Xin Dong iD, Haowen Zhuang, Yusheng Huang, Mengyuan Wang, Zhongzheng Zhang, Jinhong Chen, Wei Wang, Chun Li, Junyan Wang

Phytotherapy Research · 2026-11 · 40 (11) · 6748-6766

DOI: 10.1002/ptr.70458 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-09-23. Written by Ruijia Wen and 9 co-authors. Institution: Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. Major MEDLINE topics: Hesperidin, NF-E2-Related Factor 2, Cardiotoxicity, Doxorubicin. 58 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Science Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Doxorubicin (DOX) has antitumor efficacy, but its clinical application is restricted by multiple side effects, especially cardiotoxicity. Neohesperidin, a flavonoid in citrus fruits, has various health benefits. The aim of this study was to explore the cardioprotective effects and mechanisms of neohesperidin against DOX‐induced cardiotoxicity (DIC). The study used DOX‐treated mice to evaluate cardiac function and cardiomyocyte injury. In addition, primary cardiomyocytes treated with DOX were used to measure cell viability and death. FIN56, a ferroptosis inhibitor, was used to test the relationship between neohesperidin's beneficial effect and ferroptosis. Mechanistic investigations were carried out to explore the role of N6‐methyladenosine (m 6 A) levels, nuclear factor erythroid‐2‐related factor 2 (Nrf2) expression, and Methyltransferase‐like 3 (Mettl3) in the cardioprotective effect of neohesperidin. Overexpression and knockdown of Mettl3 were also performed to confirm its role in the cardioprotective effect. Neohesperidin attenuated cardiac function and cardiomyocyte injury in DOX‐treated mice. It alleviated DOX‐induced oxidative stress by reducing reactive oxygen species and malondialdehyde levels and increasing superoxide dismutase and glutathione levels, restoring ATP production. In DOX‐treated primary cardiomyocytes, neohesperidin increased cell viability and decreased cell death. FIN56 abolished the beneficial effect of neohesperidin. Mechanistically, neohesperidin decreased m 6 A levels, leading to increased Nrf2 expression. Nrf2 activation was related to the inhibition of Mettl3, an m 6 A “writer,” which protected cardiomyocytes against DOX‐induced ferroptosis. Overexpressing Mettl3 reversed the cardioprotective effects of neohesperidin and diminished its benefits on ferroptosis. These findings suggest that neohesperidin exerts a cardioprotective effect against DIC by inhibiting ferroptosis. This effect is achieved by regulating the Mettl3‐m 6 A‐Nrf2 signaling pathway, indicating the therapeutic potential of neohesperidin.

Subjects

MeSH terms (MEDLINE)

HesperidinNF-E2-Related Factor 2CardiotoxicityDoxorubicinFerroptosisMethyltransferasesAnimalsMyocytes, CardiacMiceSignal TransductionOxidative StressMaleCardiotonic AgentsReactive Oxygen SpeciesMice, Inbred C57BLCell Survival

Author keywords

DOXMettl3Nrf2cardiotoxicitym6Aneohesperidin

Substances

HesperidinNF-E2-Related Factor 2DoxorubicinneohesperidinMethyltransferasesCardiotonic AgentsNfe2l2 protein, mouseReactive Oxygen Species

Authors and institutions

  • Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.

ORCID profiles: Ruijia Wen, Xin Dong

Funding

  • National Natural Science Foundation of China
  • Science Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine
  • Incubation Program for the Science and Technology Development of Chinese Medicine Guangdong Laboratory
  • National Science and Technology Major Project of the Ministry of Science and Technology of China
  • GuangDong Basic and Applied Basic Research Foundation
  • National Science and Technology Major Project
  • Basic and Applied Basic Research Foundation of Guangdong Province

Cite

APA

Wen, R., Dong, X., Zhuang, H., Huang, Y., Wang, M., Zhang, Z., Chen, J., Wang, W., Li, C., & Wang, J. (2026). Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling. Phytotherapy Research, 40(11), 6748-6766. https://doi.org/10.1002/ptr.70458

Vancouver

Wen R, Dong X, Zhuang H, Huang Y, Wang M, Zhang Z, et al. Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling. Phytotherapy Research. 2026;40(11):6748-6766. doi:10.1002/ptr.70458

BibTeX
@article{Wen2026,
  author = {Wen, Ruijia and Dong, Xin and Zhuang, Haowen and Huang, Yusheng and Wang, Mengyuan and Zhang, Zhongzheng and Chen, Jinhong and Wang, Wei and Li, Chun and Wang, Junyan},
  title = {Neohesperidin Alleviates Ferroptosis in Doxorubicin‐Induced Cardiotoxicity via Mettl3‐ m 6 A ‐Nrf2 Signaling},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6748--6766},
  doi = {10.1002/ptr.70458}
}
Start for free →